Skip to main content
logo
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.58
-1.06 (-1.18%)
Aug 14, 2026, 4:00 PM EDT - Market closed

TransMedics Group Revenue

TransMedics Group had revenue of $189.95M in the quarter ending June 30, 2026, with 20.70% growth. This brings the company's revenue in the last twelve months to $668.47M, up 25.82% year-over-year. In the year 2025, TransMedics Group had annual revenue of $605.49M with 37.13% growth.

Revenue (ttm)
$668.47M
Revenue Growth
+25.82%
P/S Ratio
4.59
Revenue / Employee
$744,396
Employees
898
Market Cap
3.07B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025605.49M163.95M37.13%
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 31, 201813.02M5.33M69.38%
Dec 30, 20177.69M-5.33M-40.96%
Dec 31, 201613.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Integer Holdings1.84B
LivaNova1.47B
Haemonetics1.35B
Neogen870.40M
iRhythm Holdings825.34M
NovoCure699.19M
UFP Technologies631.64M
Axogen251.17M
Revenue Rankings

TMDX News

More News